Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Neoplasms and L1CAM[original query] |
|---|
| The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer. Anticancer research 2009 Aug 29 (8): 3449-52. Heubner Martin, Wimberger Pauline, Kasimir-Bauer Sabine, Otterbach Friedrich, Kimmig Rainer, Siffert Winfri |
| L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA). Gynecologic oncology 2016 05 141 (2): 336-340. Dellinger Thanh H, Smith David D, Ouyang Ching, Warden Charles D, Williams John C, Han Ernest |
| Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites. Oncotarget 2016 Jan . Lim Byungho, Kim Chan, Kim Jeong-Hwan, Kwon Woo Sun, Lee Won Seok, Kim Jeong Min, Park Jun Yong, Kim Hyo Song, Park Kyu Hyun, Kim Tae Soo, Park Jong-Lyul, Chung Hyun Cheol, Rha Sun Young, Kim Seon-You |
| Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer. Oncotarget 2017 Mar . van Esterik Manouk, Van Gool Inge C, de Kroon Cor D, Nout Remi A, Creutzberg Carien L, Smit Vincent T H B M, Bosse Tjalling, Stelloo Ell |
| L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile. British journal of cancer 2018 Jul . Kommoss Felix Kf, Karnezis Anthony N, Kommoss Friedrich, Talhouk Aline, Taran Florin-Andrei, Staebler Annette, Gilks C Blake, Huntsman David G, Krämer Bernhard, Brucker Sara Y, McAlpine Jessica N, Kommoss Stef |
| Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study. Gynecologic oncology 2021 7 162 (3): 694-701. Victoor Jasper, Borght Sara Vander, Spans Lien, Lehnert Stefan, Brems Hilde, Laenen Annouschka, Vergote Ignace, Van Gorp Toon, Van Nieuwenhuysen Els, Han Sileny, Timmerman Stefan, Van Rompuy Anne-Sophie, Vanden Bempt Isabel |
| Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer. Breast cancer research and treatment 2021 6 189 (1): 187-202. Ademuyiwa Foluso O, Chen Ina, Luo Jingqin, Rimawi Mothaffar F, Hagemann Ian S, Fisk Bryan, Jeffers Gejae, Skidmore Zachary L, Basu Anamika, Richters Megan, Ma Cynthia X, Weilbaecher Katherine, Davis Jennifer, Suresh Rama, Peterson Lindsay L, Bose Ron, Bagegni Nusayba, Rigden Caron E, Frith Ashley, Rearden Timothy P, Hernandez-Aya Leonel F, Roshal Anna, Clifton Katherine, Opyrchal Mateusz, Akintola-Ogunremi Olaronke, Lee Byung Ha, Ferrando-Martinez Sara, Church Sarah E, Anurag Meenakshi, Ellis Matthew J, Gao Feng, Gillanders William, Griffith Obi L, Griffith Malac |
| Druggable genetic targets in endometrial cancer. Cancer treatment and research communications 2021 12 30 100502. Lehrer Steven, Rheinstein Peter |
| Molecular Profiling of Endometrial Cancer: An Exploratory Study in Aotearoa, New Zealand. Cancers 2021 11 13 (22): . Henry Claire E, Phan Khoi, Orsman Elena J, Kenwright Diane, Thunders Michelle C, Filoche Sara |
| Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer. Nature medicine 2022 08 28 (8): 1646-1655. Chatila Walid K, Kim Jin K, Walch Henry, Marco Michael R, Chen Chin-Tung, Wu Fan, Omer Dana M, Khalil Danny N, Ganesh Karuna, Qu Xuan, Luthra Anisha, Choi Seo-Hyun, Ho Yu-Jui, Kundra Ritika, Groves Katharine I, Chow Oliver S, Cercek Andrea, Weiser Martin R, Widmar Maria, Wei Iris H, Pappou Emmanouil P, Nash Garrett M, Paty Philip B, Shi Qian, Vakiani Efsevia, Duygu Selcuklu S, Donoghue Mark T A, Solit David B, Berger Michael F, Shia Jinru, Pelossof Raphael, Romesser Paul B, Yaeger Rona, Smith J Joshua, Schultz Nikolaus, Sanchez-Vega Francisco, Garcia-Aguilar Jul |
| Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2022 3 42 (1): 43-53. Haag Jennifer G, Wolsky Rebecca J, Moroney Marisa R, Sheren Jamie, Sheeder Jeanelle, Bitler Benjamin G, Corr Bradley |
| Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine. Omics : a journal of integrative biology 2023 9 . Mansoor Ali, Rameshwar N K Bamezai, Rana P Sin |
| Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer. Gynecologic oncology 2023 5 174 231-238. Junhwan Kim, Se Ik Kim, Nae Ry Kim, Hyojin Kim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Cheol Lee, Maria L |
| Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. British journal of cancer 2023 1 . Vermij Lisa, Jobsen Jan J, León-Castillo Alicia, Brinkhuis Mariel, Roothaan Suzan, Powell Melanie E, de Boer Stephanie M, Khaw Pearly, Mileshkin Linda R, Fyles Anthony, Leary Alexandra, Genestie Catherine, Jürgenliemk-Schulz Ina M, Crosbie Emma J, Mackay Helen J, Nijman Hans W, Nout Remi A, Smit Vincent T H B M, Creutzberg Carien L, Horeweg Nanda, Bosse Tjalling, |
- Page last reviewed:Feb 1, 2024
- Content source: